Alpha Tau Medical (DRTS) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $13.16, -2.52% vs the prior close of $13.50.
- Volume 620.30K shares, 1.2x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
DRTS dips 2.5% to $13.16, a 1-month low, 4 down days in a row. Closed at $13.16, -2.52% vs the prior close of $13.50. Day range $13.02–$13.47, opened at $13.14.
DRTS daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — DRTS dips 2.5% to $13.16, a 1-month low, 4 down days in a row
- Closed at $13.16, -2.52% vs the prior close of $13.50. Day range $13.02–$13.47, opened at $13.14.
- Volume was 620.30K shares, 1.2x its 50-day average of 537.80K.
- Price is -9.0% vs its 50-day average ($14.46) and +28.9% vs its 200-day average ($10.21).
- 52-week range $3.43–$15.79; today's close sits at 79% of that range, 16.7% below the 52-week high.
- That makes 4 straight losses.
Oct 14, 2026 — DRTS dips 1.7% to $13.50, a 1-month low, 3 down days in a row
- Closed at $13.50, -1.75% vs the prior close of $13.74. Day range $13.34–$13.79, opened at $13.48.
- Volume was 422.00K shares, 0.8x its 50-day average of 541.01K.
- Price is -6.7% vs its 50-day average ($14.47) and +32.7% vs its 200-day average ($10.17).
- 52-week range $3.43–$15.79; today's close sits at 81% of that range, 14.5% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — DRTS slides 3.6% to $13.74, a 1-month low
- Closed at $13.74, -3.65% vs the prior close of $14.26. Day range $13.65–$14.25, opened at $14.11.
- Volume was 484.60K shares, 0.9x its 50-day average of 537.93K.
- Price is -5.0% vs its 50-day average ($14.46) and +35.7% vs its 200-day average ($10.13).
- 52-week range $3.43–$15.79; today's close sits at 83% of that range, 13.0% below the 52-week high.
Oct 12, 2026 — DRTS dips 1.0% to $14.26
- Closed at $14.26, -1.04% vs the prior close of $14.41. Day range $14.11–$14.44, opened at $14.42.
- Volume was 281.50K shares, 0.5x its 50-day average of 537.74K — lighter than usual.
- Price is -1.1% vs its 50-day average ($14.42) and +41.4% vs its 200-day average ($10.08).
- 52-week range $3.43–$15.79; today's close sits at 88% of that range, 9.7% below the 52-week high.
Oct 9, 2026 — DRTS rises 2.9% to $14.41
- Closed at $14.41, +2.93% vs the prior close of $14.00. Day range $13.98–$14.50, opened at $14.00.
- Volume was 368.00K shares, 0.7x its 50-day average of 542.51K.
- Price is +0.3% vs its 50-day average ($14.37) and +43.5% vs its 200-day average ($10.04).
- 52-week range $3.43–$15.79; today's close sits at 89% of that range, 8.7% below the 52-week high.
Oct 8, 2026 — DRTS dips 1.8% to $14.00, a 1-month low, 3 down days in a row
- Closed at $14.00, -1.75% vs the prior close of $14.25. Day range $13.56–$14.30, opened at $14.17.
- Volume was 595.20K shares, 1.1x its 50-day average of 544.38K.
- Price is -2.2% vs its 50-day average ($14.32) and +40.1% vs its 200-day average ($9.99).
- 52-week range $3.43–$15.79; today's close sits at 86% of that range, 11.3% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — DRTS dips 1.6% to $14.25, a 1-month low
- Closed at $14.25, -1.59% vs the prior close of $14.48. Day range $14.10–$14.44, opened at $14.27.
- Volume was 466.30K shares, 0.8x its 50-day average of 553.24K.
- Price is -0.1% vs its 50-day average ($14.27) and +43.2% vs its 200-day average ($9.95).
- 52-week range $3.43–$15.79; today's close sits at 88% of that range, 9.8% below the 52-week high.
Oct 6, 2026 — DRTS dips 2.8% to $14.48
- Closed at $14.48, -2.75% vs the prior close of $14.89. Day range $14.40–$15.02, opened at $14.98.
- Volume was 427.40K shares, 0.8x its 50-day average of 554.77K.
- Price is +1.9% vs its 50-day average ($14.21) and +46.2% vs its 200-day average ($9.90).
- 52-week range $3.43–$15.79; today's close sits at 89% of that range, 8.3% below the 52-week high.
Oct 5, 2026 — DRTS rises 0.8% to $14.89
- Closed at $14.89, +0.81% vs the prior close of $14.77. Day range $14.68–$15.04, opened at $14.85.
- Volume was 342.40K shares, 0.6x its 50-day average of 555.21K.
- Price is +5.1% vs its 50-day average ($14.17) and +51.1% vs its 200-day average ($9.85).
- 52-week range $3.43–$15.79; today's close sits at 93% of that range, 5.7% below the 52-week high.
Oct 2, 2026 — DRTS rises 1.8% to $14.77
- Closed at $14.77, +1.79% vs the prior close of $14.51. Day range $14.64–$14.91, opened at $14.73.
- Volume was 307.10K shares, 0.6x its 50-day average of 558.29K — lighter than usual.
- Price is +4.6% vs its 50-day average ($14.12) and +50.6% vs its 200-day average ($9.80).
- 52-week range $3.43–$15.79; today's close sits at 92% of that range, 6.5% below the 52-week high.
DRTS latest news & SEC filings
Every SEC filing by or about DRTS in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 31, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 25, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Levy Raphi sold 2,871 shares at $15.00 (≈$43.06K) on Aug 21, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 21, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 12, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Levy Raphi sold 17,730 shares at $14.00 (≈$248.22K) on Aug 11, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 10, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 10, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 21, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 15, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 7, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Levy Raphi sold 2,270 shares at $14.00 (≈$31.78K) on Jul 6, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jul 6, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Jul 6, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Levy Raphi sold 17,873 shares at $13.00 (≈$232.35K) on Jul 2, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jun 25, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jun 23, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade DRTS
- How much it moves: over the last 20 sessions the average daily move was 2.13% (largest 4.1%).
- Liquidity: about 450.01K shares (≈$5.92M) trade per day on average.
- 52-week position: $13.16 vs a range of $3.43–$15.79 (79% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 12 sales; latest: Raphi Levy sold 2,871 shares on Aug 21, 2026.
- Latest filings: 6-K Aug 31, 2026; 6-K Aug 10, 2026; 6-K Aug 10, 2026.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
DRTS market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 13.14 | 13.47 | 13.02 | 13.16 | 620.30K |
| Oct 14, 2026 | 13.48 | 13.79 | 13.34 | 13.50 | 422.00K |
| Oct 13, 2026 | 14.11 | 14.25 | 13.65 | 13.74 | 484.60K |
| Oct 12, 2026 | 14.42 | 14.44 | 14.11 | 14.26 | 281.50K |
| Oct 9, 2026 | 14.00 | 14.50 | 13.98 | 14.41 | 368.00K |
| Oct 8, 2026 | 14.17 | 14.30 | 13.56 | 14.00 | 595.20K |
| Oct 7, 2026 | 14.27 | 14.44 | 14.10 | 14.25 | 466.30K |
| Oct 6, 2026 | 14.98 | 15.02 | 14.40 | 14.48 | 427.40K |
| Oct 5, 2026 | 14.85 | 15.04 | 14.68 | 14.89 | 342.40K |
| Oct 2, 2026 | 14.73 | 14.91 | 14.64 | 14.77 | 307.10K |
| Oct 1, 2026 | 14.74 | 14.97 | 14.32 | 14.51 | 379.90K |
| Sep 30, 2026 | 15.14 | 15.34 | 14.88 | 14.91 | 368.90K |
| Sep 29, 2026 | 15.00 | 15.30 | 14.77 | 15.19 | 513.90K |
| Sep 28, 2026 | 14.54 | 15.20 | 14.39 | 15.04 | 397.40K |
| Sep 25, 2026 | 14.90 | 14.92 | 14.39 | 14.54 | 435.40K |
| Sep 24, 2026 | 14.50 | 14.80 | 14.31 | 14.77 | 467.00K |
| Sep 23, 2026 | 15.09 | 15.25 | 14.31 | 14.52 | 727.00K |
| Sep 22, 2026 | 15.38 | 15.45 | 15.05 | 15.14 | 360.40K |
| Sep 21, 2026 | 15.48 | 15.59 | 15.10 | 15.50 | 411.40K |
| Sep 18, 2026 | 15.60 | 15.62 | 15.10 | 15.24 | 624.20K |
About Alpha Tau Medical
Alpha Tau Medical (DRTS) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in JERUSALEM, Israel. State of incorporation: Israel. Fiscal year ends December 31. SEC CIK 1871321.
DRTS board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Alan Adler | Director | Mar 18, 2026 |
| Ruth Alon | Director | Mar 18, 2026 |
| Michael Avruch | Director | Mar 18, 2026 |
| S Morry Blumenfeld | Director | Mar 18, 2026 |
| Nadav Kidron | Director | Mar 18, 2026 |
| David Mark Milch | Director | Mar 18, 2026 |
| Maya Netser | Director | Mar 18, 2026 |
| Uzi Sofer | Chief Executive Officer | Mar 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Raphi Levy | Chief Financial Officer | Aug 25, 2026 |
| Uzi Sofer | Chief Executive Officer | Mar 18, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 21, 2026 | Raphi Levy | Sale | 2,871 | $15.00 |
| Aug 11, 2026 | Raphi Levy | Sale | 17,730 | $14.00 |
| Jul 6, 2026 | Raphi Levy | Sale | 2,270 | $14.00 |
| Jul 2, 2026 | Raphi Levy | Sale | 17,873 | $13.00 |
| Jul 1, 2026 | Raphi Levy | Sale | 2,127 | $13.02 |
| Jun 30, 2026 | Raphi Levy | Sale | 20,000 | $12.00 |
| Jun 25, 2026 | Raphi Levy | Sale | 4,222 | $11.00 |
| Jun 25, 2026 | Raphi Levy | Sale | 15,778 | $11.00 |
| Jun 23, 2026 | Raphi Levy | Sale | 15,000 | $9.47 |
| Jun 23, 2026 | Raphi Levy | Sale | 2,500 | $10.00 |
| Jun 3, 2026 | Raphi Levy | Sale | 15,000 | $10.76 |
| Jun 3, 2026 | Raphi Levy | Sale | 17,500 | $10.90 |
DRTS financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
DRTS earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Surgical & Medical Instruments & Apparatus
Stryker (SYK)Boston Scientific (BSX)3M (MMM)MiniMed (MMED)Dexcom (DXCM)Becton Dickinson (BDX)Medline (MDLN)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on DRTS
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.